(Q35535955)

8 August 2017

1 reference

title

Cardiovascular magnetic resonance for amyloidosis (English)

1 reference

8 August 2017

4

James C Moon

1 reference

8 August 2017

Marianna Fontana

1

1 reference

PubMed ID

25549885

8 August 2017

Robin Chung

series ordinal

2

1 reference

PubMed ID

25549885

8 August 2017

Philip N Hawkins

series ordinal

3

1 reference

8 August 2017

1 March 2015

1 reference

8 August 2017

Heart Failure Reviews

1 reference

8 August 2017

20

1 reference

8 August 2017

2

1 reference

8 August 2017

133-144

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-014-9470-7

8 August 2017

0 references

cites work

The systemic amyloidoses

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

Cardiovascular magnetic resonance in cardiac amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

T1-mapping in the heart: accuracy and precision

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

T₁ mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

Native T1 mapping in transthyretin amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

Myocardial T1 and extracellular volume fraction mapping at 3 tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

AL and ATTR cardiac amyloid are different: native T1 mapping and ECV detect different biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

Quantification of extracellular matrix expansion by CMR in infiltrative heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

Prognostic significance of strain Doppler imaging in light-chain amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

New pathological insights into cardiac amyloidosis: implications for non-invasive diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9470-7

T1 mapping and survival in systemic light-chain amyloidosis

21 January 2018

1 reference

12 December 2020

Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy

1 reference

12 December 2020

Amyloid substance within stenotic aortic valves promotes mineralization

1 reference

12 December 2020

Differences in myocardial velocity gradient measured throughout the cardiac cycle in patients with hypertrophic cardiomyopathy, athletes and patients with left ventricular hypertrophy due to hypertension

1 reference

12 December 2020

Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis

1 reference

12 December 2020

Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE.

1 reference

12 December 2020

Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis

1 reference

12 December 2020

Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload.

1 reference

12 December 2020

Cardiovascular magnetic resonance in cardiac amyloidosis

1 reference

12 December 2020

Cardiac amyloidosis: evolving approach to diagnosis and management

1 reference

12 December 2020

Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis

1 reference

12 December 2020

10.1007/S10741-014-9470-7

Identifiers

DOI

1 reference

8 August 2017

1 reference

PubMed ID

25549885